Male Menopause: Another Treatment for Pharmaceutical Companies

The Washington Post came out with a long article today about how researchers, doctors, and drug companies are looking at something new to treat: male menopause, or as the article describes it, ‘manopause’. There will always be a new and different condition that will require some sort of cure or treatment. I’m looking for a treatment for ‘acute poor trading syndrome.’But seriously, the big pharmas have plenty of drugs in the pipeline. And while you are wating for the bid payoff, you can always receive a dividend, as according to WallStreetNewsNetwork.com, there are about ten high yield big pharmaceutical stocks, and half of them have yields over 3%.Eli Lilly & Co. (LLY) trades at eight times forward earnings and sports an extremely generous yield of 5.4%. Earnings were up 16% for the latest quarter and the company’s next earnings announcement will be October 21.Merck & Co., Inc. (MRK) trades at around nine times forward earnings and pays a yield of 4.1%. Earnings were down over 51% for the latest quarter, however, revenues almost doubled. Latest earnings announcement will be October 29.To see a free recently updated list of all the high yield large pharmaceutical stocks, that can be downloaded and sorted, go to WallStreetNewsNetwork.com.Disclosure: Author did not own any of the above at the time it was written.By Stockerblog.com

Stock Investing Guide

Start Trading Like a Profesional